The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often considered as outdated and hindering https://jaypvzr239435.mappywiki.com/2020285/cannabinoid_rescheduling_a_expansion_catalyst